开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2022-04-19 沧海医僧笑

偏重的研究方向：遗传学
经验分享：under review了，中的机率大吗

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2022-07-19 1487bd86m38(暂无昵称)

为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2022-02-05 ms8000001439069436

偏重的研究方向：医学;遗传学
经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位

60 0

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

讨论中一般可以讨论什么？

101 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2021-12-27 衣谷

讨论中我和之前发表文章结果不一致怎么处理？

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2019-05-06 m18814091136_98618147

投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。

266 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2021-08-26 一把辛酸泪

审稿速度:6.0
偏重的研究方向：甲低
经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。

85 0

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2019-01-03 1e0c5345m16(暂无匿称)

请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？

277 0

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2018-05-08 lovetcm

@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名

336 0

[GetPortalCommentsPageByObjectIdResponse(id=1212451, encodeId=e55c121245118, content=偏重的研究方向：遗传学 经验分享：under review了，中的机率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Tue Apr 19 10:37:15 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233517, encodeId=5df9123351e91, content=为什么我通过网站推荐的链接提交手稿总是不成功，提示作者及从属单位不正确，可我仔细检查都没啥问题呀，大家都是通过哪里提交的呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17785307018, createdName=1487bd86m38(暂无昵称), createdTime=Tue Jul 19 23:30:42 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190414, encodeId=5e351190414e1, content=偏重的研究方向：医学;遗传学 经验分享：各位亲，有投稿链接吗？有的话可否发一下，谢谢各位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6bc6478202, createdName=ms8000001439069436, createdTime=Sat Feb 05 23:01:55 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098575, encodeId=3d0b10985e5bd, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098576, encodeId=23f610985e615, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570494, encodeId=76d55e0494ce, content=投稿之后4天直接transfer了，进度很快，拒绝了移交稿件到clinical case reports。准备再试试其他sci杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97942560688, createdName=m18814091136_98618147, createdTime=Mon May 06 00:00:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011605, encodeId=574310116050a, content=审稿速度:6.0 偏重的研究方向：甲低 经验分享：2月20日投稿，4月8日返回大修意见；5月11号修回，6月5号返回大修意见；6月29号修回，7月24号返回小修意见；7月27日再次修回，8月24日文章接收。投稿经历两次大修一次小修历时半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a66a5585339, createdName=一把辛酸泪, createdTime=Thu Aug 26 08:35:12 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565116, encodeId=39df565116a1, content=请教！中英文知情同意书啥时候要？大家都怎么整的知情同意书？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160726/IMG579779B47D1B56188.jpg, createdBy=0f031928834, createdName=1e0c5345m16(暂无匿称), createdTime=Thu Jan 03 17:31:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555856, encodeId=4d65555856cb, content=@18788559030 知情同意书提供中文加英文翻译后两个版本，但中文版本应该有签名, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue May 08 22:26:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549176, encodeId=cb085491e654, content=投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48d22101287, createdName=1871f69203m, createdTime=Mon Nov 13 16:47:00 CST 2017, time=2017-11-13, status=1, ipAttribution=)]

2017-11-13 1871f69203m

投该杂志时需要提交患者知情同意书。请问你们是怎么写的，用英文还是中文？

380 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务